Microsomal epoxide hydrolase 1 (EPHX1): Gene, structure, function, and role in human disease

Gene

Volumn 571, Issue 1, 2015, Pages 1-8

  Václavíková, Radka ^a   Hughes, David J ^b   Souček, Pavel ^a,c  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Disease; EPHX1; Function; Gene; Genotype; Structure

Indexed keywords

ALCOHOL DERIVATIVE; EPOXIDE; EPHX1 PROTEIN, HUMAN; EPOXIDE HYDROLASE;

BIOTRANSFORMATION; ENZYME SPECIFICITY; EPOXIDE HYDROLASE 1 GENE; GENE; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; ALCOHOL LIVER DISEASE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; NEOPLASM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EPOXIDE HYDROLASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER DISEASES, ALCOHOLIC; MUTATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SUBSTRATE SPECIFICITY;

EID: 84939266077     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.07.071     Document Type: Review

References (131)

1. Abdull Razis A.F., Bagatta M., De Nicola G.R., Iori R., Ioannides C. Induction of epoxide hydrolase and glucuronosyl transferase by isothiocyanates and intact glucosinolates in precision-cut rat liver slices: importance of side-chain substituent and chirality. Arch. Toxicol. 2011, 85:919-927.
2. Agudo A., Peluso M., Sala N., Capellá G., Munnia A., Piro S., Marín F., Ibáñez R., Amiano P., Tormo M.J., Ardanaz E., Barricarte A., Chirlaque M.D., Dorronsoro M., Larrañaga N., Martínez C., Navarro C., Quirós J.R., Sánchez M.J., González C.A. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort. Carcinogenesis 2009, 30:968-976.
3. Akatsuka T., Tohmatsu J., Yoshihara N., Katsuhara N., Okamoto T., Shikata T., Odaka T. Detection of an antigen (AN6520) possibly related to non-A, non-B hepatitis, by monoclonal antibodies. I. J. Med. Virol. 1986, 20:33-42.
4. Akatsuka T., Kobayashi N., Ishikawa T., Saito T., Shindo M., Yamauchi M., Kurokohchi K., Miyazawa H., Duan H., Matsunaga T., Komoda T., Morisseau C., Hammock B.D. Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J. Autoimmun. 2007, 28:7-18.
5. Alves C., von Dippe P., Amoui M., Levy D. Bile acid transport into hepatocyte smooth endoplasmic reticulum vesicles is mediated by microsomal epoxide hydrolase, a membrane protein exhibiting two distinct topological orientations. J. Biol. Chem. 1993, 268:20148-20155.
6. +-dependent bile acid transport protein using monoclonal antibodies. J. Biol. Chem. 1988, 263:8338-8343.
7. Andrew A.S., Gui J., Sanderson A.C., Mason R.A., Morlock E.V., Schned A.R., Kelsey K.T., Marsit C.J., Moore J.H., Karagas M.R. Bladder cancer SNP panel predicts susceptibility and survival. Hum. Genet. 2009, 125:527-539.
8. Arand M., Grant D.F., Beetham J.K., Friedberg T., Oesch F., Hammock B.D. Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins. FEBS Lett. 1994, 338:251-256.
9. Armstrong R.N., Kedzierski B., Levin W., Jerina D.M. Enantioselectivity of microsomal epoxide hydrolase toward arene oxide substrates. J. Biol. Chem. 1981, 256:4726-4733.
10. Azzato E.M., Chen R.A., Wacholder S., Chanock S.J., Klebanoff M.A., Caporaso N.E. Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations. Pharmacogenet. Genomics 2010, 20:58-63.
11. Backman J.T., Siegle I., Zanger U.M., Fritz P. Immunohistochemical detection of microsomal epoxide hydrolase in human synovial tissue. Histochem. J. 1999, 31:645-649.
12. Barth S., Fischer M., Schmid R.D., Pleiss J. Sequence and structure of epoxide hydrolases: a systematic analysis. Proteins 2004, 55:846-855.
13. Bauer A.K., Faiola B., Abernethy D.J., Marchan R., Pluta L.J., Wong V.A., Gonzalez F.J., Butterworth B.E., Borghoff S.J., Everitt J.I., Recio L. Male mice deficient in microsomal epoxide hydrolase are not susceptible to benzene-induced toxicity. Toxicol. Sci. 2003, 72:201-209.
14. Beetham J.K., Grant D., Arand M., Garbarino J., Kiyosue T., Pinot F., Oesch F., Belknap W.R., Shinozaki K., Hammock B.D. Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell Biol. 1995, 14:61-71.
15. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998, 58:5291-5293.
16. Bhaskar L.V., Thangaraj K., Patel M., Shah A.M., Gopal K., Saikrishna L., Tamang R., Singh L., Rao V.R. EPHX1 gene polymorphisms in alcohol dependence and their distribution among the Indian populations. Am. J. Drug Alcohol Abuse 2013, 39:16-22.
17. Buehler B.A., Delimont D., van Waes M., Finnell R.H. Prenatal prediction of risk of the fetal hydantoin syndrome. N. Engl. J. Med. 1990, 322:1567-1571.
18. Carbonari D., Mansi A., Proietto A.R., Paci E., Bonanni R.C., Gherardi M., Gatto M.P., Sisto R., Tranfo G. Influence of genetic polymorphisms of styrene-metabolizing enzymes on the levels of urinary biomarkers of styrene exposure. Toxicol. Lett. 2015, 233:156-162.
19. Caruso A., Bellia C., Pivetti A., Agnello L., Bazza F., Scazzone C., Bivona G., Lo Sasso B., Ciaccio M. Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients. Pharmacogenomics Personalized Med. 2014, 7:117-120.
20. Casson A.G., Zheng Z., Porter G.A., Guernsey D.L. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Detect. Prev. 2006, 30:423-431.
21. Catsburg C., Joshi A.D., Corral R., Lewinger J.P., Koo J., John E.M., Ingles S.A., Stern M.C. Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis 2012, 33:1352-1359.
22. Chen J.Y., Chen W.N., Liu L.L., Lin W.S., Jiao B.Y., Wu Y.L., Lin J.Y., Lin X. Hepatitis B spliced protein (HBSP) generated by a spliced hepatitis B virus RNA participates in abnormality of fibrin formation and functions by binding to fibrinogen gamma chain. J. Med. Virol. 2010, 82:2019-2026.
23. Chen J.Y., Chen W.N., Jiao B.Y., Lin W.S., Wu Y.L., Liu L.L., Lin X. Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activity. BMC Cancer 2014, 14:282.
24. Cho M.K., Kim S.G. Differential induction of rat hepatic microsomal epoxide hydrolase and rGSTA2 by diazines: the role of cytochrome P450 2E1-mediated metabolic activation. Chem. Biol. Interact. 1998, 116:229-245.
25. Coller J.K., Fritz P., Zanger U.M., Siegle I., Eichelbaun M., Kroemer H.K., Mürdter T.E. Distribution of microsomal epoxide hydrolase in humans: an immunohistochemical study in normal tissues, and benign and malignant tumours. Histochem. J. 2001, 33:329-336.
26. Costa C., Costa S., Silva S., Coelho P., Botelho M., Gaspar J., Rueff J., Laffon B., Teixeira J.P. DNA damage and susceptibility assessment in industrial workers exposed to styrene. J. Toxicol. Environ. Health A 2012, 75:735-746.
27. Craft J.A., Baird S., Lamont M., Burchell B. Membrane topology of epoxide hydrolase. Biochim. Biophys. Acta 1990, 1046:32-39.
28. Decker M., Arand M., Cronin A. Mammalian epoxide hydrolases in xenobiotic metabolism and signaling. Arch. Toxicol. 2009, 83:297-318.
29. Duan H., Takagi A., Kayano H., Koyama I., Morisseau C., Hammock B.D., Akatsuka T. Monoclonal antibodies reveal multiple forms of expression of human microsomal epoxide hydrolase. Toxicol. Appl. Pharmacol. 2012, 260:27-34.
30. Duan C.Y., Liu M.Y., Li S.B., Ma K.S., Bie P. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis. Tumour Biol. 2014, 35:659-666.
31. El-Sherbeni A.A., El-Kadi A.O. The role of epoxide hydrolases in health and disease. Arch. Toxicol. 2014, 88:2013-2032.
32. Esteban-Jurado C., Vila-Casadesús M., Garre P., Lozano J.J., Pristoupilova A., Beltran S., Muñoz J., Ocaña T., Balaguer F., López-Cerón M., Cuatrecasas M., Franch-Expósito S., Piqué J.M., Castells A., Carracedo A., Ruiz-Ponte C., Abulí A., Bessa X., Andreu M., Bujanda L., Caldés T., Castellví-Bel S. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer. Genet. Med. 2015, 17:131-142.
33. Farin F.M., Omiecinski C.J. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J. Toxicol. Environ. Health 1993, 40:317-335.
34. Fathy M., Hamed M., Youssif O., Fawzy N., Ashour W. Association between environmental tobacco smoke exposure and lung cancer susceptibility: modification by antioxidant enzyme genetic polymorphisms. Mol. Diagn. Ther. 2014, 18:55-62.
35. Fretland A.J., Omiecinski C.J. Epoxide hydrolases: biochemistry and molecular biology. Chem. Biol. Interact. 2000, 129:41-59.
36. Fritz P., Behrle E., Zanger U.M., Mürdter T., Schwarzmann P., Kroemer H.K. Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach. Xenobiotica 1996, 26:107-116.
37. Fritz P., Mürdter T.E., Eichelbaum M., Siegle I., Weissert M., Zanger U.M. Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: a retrospective exploratory study with long-term follow-up. J. Clin. Oncol. 2001, 19:3-9.
38. Gaedigk A., Spielberg S.P., Grant D.M. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 1994, 4:142-153.
39. Gaedigk A., Leeder J.S., Grant D.M. Tissue-specific expression and alternative splicing of human microsomal epoxide hydrolase. DNA Cell Biol. 1997, 16:1257-1266.
40. Gill S.S., Ota K., Ruebner B., Hammock B.D. Microsomal and cytosolic epoxide hydrolase in rhesus monkey liver, and in normal and neoplastic human liver. Life Sci. 1983, 32:2693-2700.
41. Gilsing A.M., Berndt S.I., Ruder E.H., Graubard B.I., Ferrucci L.M., Burdett L., Weissfeld J.L., Cross A.J., Sinha R. Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis 2012, 33:1332-1339.
42. Goode E.L., White K.L., Vierkant R.A., Phelan C.M., Cunningham J.M., Schildkraut J.M., Berchuck A., Larson M.C., Fridley B.L., Olson J.E., Webb P.M., Chen X., Beesley J., Chenevix-Trench G., Sellers T.A. Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Mol. Carcinog. 2011, 50:397-402.
43. Hammock B.D., Storms D.H., Grant D.F. Epoxide hydrolases. Comprehensive Toxicology 1997, vol. 3:283-305. Pergamon, Oxford.
44. Hardwick J.P., Gonzalez F.J., Kasper C.B. Transcriptional regulation of rat liver epoxide hydratase, NADPH-Cytochrome P-450 oxidoreductase, and cytochrome P-450b genes by phenobarbital. J. Biol. Chem. 1983, 258:8081-8085.
45. Harris T.R., Hammock B.D. Soluble epoxide hydrolase: gene structure, expression and deletion. Gene 2013, 526:61-74.
46. Hartsfield J.K., Sutcliffe M.J., Everett E.T., Hassett C., Omiecinski C.J., Saari J.A. Assignment of microsomal epoxide hydrolase (EPHX1) to human chromosome 1q42.1 by in situ hybridization. Cytogenet. Cell Genet. 1998, 83:44-45.
47. Hassett C., Robinson K.B., Beck N.B., Omiecinski C.J. The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 1994, 23:433-442.
48. Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 1994, 3:421-428.
49. Hassett C., Lin J., Carty C.L., Laurenzana E.M., Omiecinski C.J. Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch. Biochem. Biophys. 1997, 337:275-283.
50. Hassett C., Laurenzana E.M., Sidhu J.S., Omiecinski C.J. Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem. Pharmacol. 1998, 55:1059-1069.
51. Heininger K. A unifying hypothesis of Alzheimer's disease. III. Risk factors. Hum. Psychopharmacol. 2000, 15:1-70.
52. Hemminki K., Frank C., Försti A., Musak L., Kazimirova A., Barancokova M., Horska A., Vymetalkova V., Smerhovsky Z., Naccarati A., Soucek P., Vodickova L., Buchancova J., Smolkova B., Dusinska M., Vodicka P. Metabolic gene variants associated with chromosomal aberrations in healthy humans. Genes Chromosomes Cancer 2015, 54:260-266.
53. Hlavata I., Vrana D., Smerhovsky Z., Pardini B., Naccarati A., Vodicka P., Novotny J., Mohelnikova-Duchonova B., Soucek P. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population. Oncol. Rep. 2010, 24:1347-1353.
54. Honscha W., Oesch F., Friedberg T. Tissue-specific expression and differential inducibility of several microsomal epoxide hydrolase mRNAs which are formed by alternative splicing. Arch. Biochem. Biophys. 1991, 287:380-385.
55. Hosagrahara V.P., Rettie A.E., Hassett C., Omiecinski C.J. Functional analysis of human microsomal epoxide hydrolase genetic variants. Chem. Biol. Interact. 2004, 150:149-159.
56. Hu J.J., Wang Z.T., Li B. Meta-analysis demonstrates lack of an association of microsomal epoxide hydrolase 1 polymorphisms with esophageal cancer risk. Genet. Mol. Res. 2013, 12:4540-4548.
57. Jackson M.R., Craft J.A., Burchell B. Nucleotide and deduced amino acid sequence of human liver microsomal epoxide hydrolase. Nucleic Acids Res. 1987, 15:7188.
58. Jourenkova-Mironova N., Mitrunen K., Bouchardy C., Dayer P., Benhamou S., Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res. 2000, 60:534-536.
59. Kessler R., Hamou M.F., Albertoni M., de Tribolet N., Arand M., Van Meir E.G. Identification of the putative brain tumor antigen BF7/GE2 as the (de)toxifying enzyme microsomal epoxide hydrolase. Cancer Res. 2000, 60:1403-1409.
60. Khedhaier A., Hassen E., Bouaouina N., Gabbouj S., Ahmed S.B., Chouchane L. Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 2008, 8:109.
61. Kim S.K., Woodcroft K.J., Kim S.G., Novak R.F. Insulin and glucagon signaling in regulation of microsomal epoxide hydrolase expression in primary cultured rat hepatocytes. Drug Metab. Dispos. 2003, 31:1260-1268.
62. Kim S., Lan Q., Waidyanatha S., Chanock S., Johnson B.A., Vermeulen R., Smith M.T., Zhang L., Li G., Shen M., Yin S., Rothman N., Rappaport S.M. Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet. Genomics 2007, 17:789-801.
63. Kitteringham N.R., Davis C., Howard N., Pirmohamed M., Park B.K. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. J. Pharmacol. Exp. Ther. 1996, 278:1018-1027.
64. Laasanen J., Romppanen E.L., Hiltunen M., Helisalmi S., Mannermaa A., Punnonen K., Heinonen S. Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia. Eur. J. Hum. Genet. 2002, 10:569-573.
65. Laffon B., Pérez-Cadahía B., Pásaro E., Méndez J. Effect of epoxide hydrolase and glutathione S-tranferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutat. Res. 2003, 536:49-59.
66. Landi S., Gemignani F., Moreno V., Gioia-Patricola L., Chabrier A., Guino E., Navarro M., de Oca J., Capellà G., Canzian F., Bellvitge Colorectal Cancer Study Group A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet. Genomics 2005, 15:535-546.
67. Lee J., Dahl M., Nordestgaard B.G. Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1673-1682.
68. Lewis D.F., Lake B.G., Bird M.G. Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity. Toxicol. In Vitro 2005, 19:517-522.
69. Li H., Fu W.P., Hong Z.H. Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: a comprehensive meta-analysis. Oncol. Lett. 2013, 5:1022-1030.
70. Liang S.H., Hassett C., Omiecinski C.J. Alternative promoters determine tissue-specific expression profiles of the human microsomal epoxide hydrolase gene (EPHX1). Mol. Pharmacol. 2005, 67:220-230.
71. Liu M., Sun A., Shin E.J., Liu X., Kim S.G., Runyons C.R., Markesbery W., Kim H.C., Bing G. Expression of microsomal epoxide hydrolase is elevated in Alzheimer's hippocampus and induced by exogenous beta-amyloid and trimethyl-tin. Eur. J. Neurosci. 2006, 23:2027-2034.
72. Liu F., Yuan D., Wei Y., Wang W., Yan L., Wen T., Xu M., Yang J., Li B. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk. PLoS One 2012, 7:e43821.
73. Liu H.Q., Zhang C.P., Zhang C.Z., Liu X.C., Liu Z.J. Influence of two common polymorphisms in the EPHX1 gene on warfarin maintenance dosage: a meta-analysis. Biomed. Res. Int. 2015, 2015:564149.
74. Lu A.Y., Thomas P.E., Ryan D., Jerina D.M., Levin W. Purification of human liver microsomal epoxide hydrase. Differences in the properties of the human and rat enzymes. J. Biol. Chem. 1979, 254:5878-5881.
75. Marowsky A., Burgener J., Falck J.R., Fritschy J.M., Arand M. Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience 2009, 163:646-661.
76. Masoodi T.A., Rao Talluri V., Shaik N.A., Al-Aama J.Y., Hasan Q. Functional genomics based prioritization of potential nsSNPs in EPHX1, GSTT1, GSTM1 and GSTP1 genes for breast cancer susceptibility studies. Genomics 2012, 99:330-339.
77. Mertes I., Fleischmann R., Glatt H.R., Oesch F. Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. Carcinogenesis 1985, 6:219-223.
78. Mitrou P.N., Watson M.A., Loktionov A.S., Cardwell C., Gunter M.J., Atkin W.S., Macklin C.P., Cecil T., Bishop D.T., Primrose J., Bingham S.A. Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS study. Carcinogenesis 2007, 28:875-882.
79. Miyata M., Kudo G., Lee Y.H., Yang T.J., Gelboin H.V., Fernandez-Salguero P., Kimura S., Gonzalez F.J. Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J. Biol. Chem. 1999, 274:23963-23968.
80. Morisseau C., Newman J.W., Wheelock C.E., Hill Iii T., Morin D., Buckpitt A.R., Hammock B.D. Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase. Chem. Res. Toxicol. 2008, 21:951-957.
81. Murray G.I., Weaver R.J., Paterson P.J., Ewen S.W., Melvin W.T., Burke M.D. Expression of xenobiotic metabolizing enzymes in breast cancer. J. Pathol. 1993, 169:347-353.
82. Nakajima Y., Saito Y., Shiseki K., Fukushima-Uesaka H., Hasegawa R., Ozawa S., Sugai K., Katoh M., Saitoh O., Ohnuma T., Kawai M., Ohtsuki T., Suzuki C., Minami N., Kimura H., Goto Y., Kamatani N., Kaniwa N., Sawada J. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Eur. J. Clin. Pharmacol. 2005, 61:25-34.
83. Newman J.W., Morisseau C., Hammock B.D. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog. Lipid Res. 2005, 44:1-51.
84. Nguyen H.L., Yang X., Omiecinski C.J. Expression of a novel mRNA transcript for human microsomal epoxide hydrolase (EPHX1) is regulated by short open reading frames within its 5'-untranslated region. RNA 2013, 19:752-766.
85. Nithipatikom K., Endsley M.P., Pfeiffer A.W., Falck J.R., Campbell W.B. A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. J. Lipid Res. 2014, 55:2093-2102.
86. Oesch F. Purification and specificity of a human microsomal epoxide hydratase. Biochem. J. 1974, 139:77-88.
87. Oesch F., Jerina D.M., Daly J.W. Substrate specificity of hepatic epoxide hydrase in microsomes and in a purified preparation: evidence for homologous enzymes. Arch. Biochem. Biophys. 1971, 144:253-261.
88. Oesch F., Kaubisch N., Jerina D.M., Daly J.W. Hepatic epoxide hydrase. Structure-activity relationships for substrates and inhibitors. Biochemistry 1971, 10:4858-4866.
89. Oesch F., Raphael D., Schwind H., Glatt H.R. Species differences in activating and inactivating enzymes related to the control of mutagenic metabolites. Arch. Toxicol. 1977, 39:97-108.
90. Oesch F., Herrero M.E., Hengstler J.G., Lohmann M., Arand M. Metabolic detoxification: implications for thresholds. Toxicol. Pathol. 2000, 28:382-387.
91. Ollis D.L., Cheah E., Cygler M., Dijkstra B., Frolow F., Franken S.M., Harel M., Remington S.J., Silman I., Schrag J., Sussman J.L., Verschueren K.H.G., Goldman A. The α/β hydrolase fold. Protein Eng. 1992, 5:197-211.
92. Peluso M.E., Munnia A., Srivatanakul P., Jedpiyawongse A., Sangrajrang S., Ceppi M., Godschalk R.W., van Schooten F.J., Boffetta P. DNA adducts and combinations of multiple lung cancer at-risk alleles in environmentally exposed and smoking subjects. Environ. Mol. Mutagen. 2013, 54:375-383.
93. Peng D.R., Pacifici G.M., Rane A. Human fetal liver cultures: basal activities and inducibility of epoxide hydrolases and aryl hydrocarbon hydroxylase. Biochem. Pharmacol. 1984, 33:71-77.
94. Peng H., Zhu Q.S., Zhong S., Levy D. Transcription of the human microsomal epoxide hydrolase gene (EPHX1) is regulated by an HNF-4α/CAR/RXR/PSF complex. Biochim. Biophys. Acta. 2013, 1829:1000-1009.
95. Pérez-Morales R., Méndez-Ramírez I., Moreno-Macias H., Mendoza-Posadas A.D., Martínez-Ramírez O.C., Castro-Hernández C., Gonsebatt M.E., Rubio J. Genetic susceptibility to lung cancer based on candidate genes in a sample from the Mexican Mestizo population: a case-control study. Lung 2014, 192:167-173.
96. Popp S.L., Abele I.S., Buck M.B., Stope M.B., Blok L.J., Hanifi-Moghaddam P., Burger C.W., Fritz P., Knabbe C. Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle. J. Mol. Histol. 2010, 41:111-119.
97. Puranik Y.G., Birnbaum A.K., Marino S.E., Ahmed G., Cloyd J.C., Remmel R.P., Leppik I.E., Lamba J.K. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. Pharmacogenomics 2013, 14:35-45.
98. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., Ioannides C. Differential response of human and rat epoxide hydrolase to polycyclic aromatic hydrocarbon exposure: studies using precision-cut tissue slices. Mutat. Res. 2008, 640:153-161.
99. Rawal S., Morisseau C., Hammock B.D., Shivachar A.C. Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes. J. Neurosci. Res. 2009, 87:218-227.
100. Rotunno M., Yu K., Lubin J.H., Consonni D., Pesatori A.C., Goldstein A.M., Goldin L.R., Wacholder S., Welch R., Burdette L., Chanock S.J., Bertazzi P.A., Tucker M.A., Caporaso N.E., Chatterjee N., Bergen A.W., Landi M.T. Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression. PLoS One 2009, 4:e5652.
101. Sarmanová J., Benesová K., Gut I., Nedelcheva-Kristensen V., Tynková L., Soucek P. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum. Mol. Genet. 2001, 10:1265-1273.
102. Sarmanová J., Sůsová S., Gut I., Mrhalová M., Kodet R., Adámek J., Roth Z., Soucek P. Breast cancer: role of polymorphisms in biotransformation enzymes. Eur. J. Hum. Genet. 2004, 12:848-854.
103. Shin E.J., Bing G., Chae J.S., Kim T.W., Bach J.H., Park D.H., Yamada K., Nabeshima T., Kim H.C. Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice. J. Neurosci. Res. 2009, 87:3679-3686.
104. Shou M., Gonzalez F.J., Gelboin H.V. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry 1996, 35:15807-15813.
105. Silveira Vda S., Canalle R., Scrideli C.A., Queiroz R.G., Tone L.G. Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ. Mol. Mutagen. 2010, 51:48-56.
106. Skoda R.C., Demierre A., McBride O.W., Gonzalez F.J., Meyer U.A. Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. J. Biol. Chem. 1988, 263:1549-1554.
107. Spurdle A.B., Chang J.H., Byrnes G.B., Chen X., Dite G.S., McCredie M.R., Giles G.G., Southey M.C., Chenevix-Trench G., Hopper J.L. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 2007, 16:769-774.
108. Su S., Omiecinski C.J. Sp1 and Sp3 transcription factors regulate the basal expression of human microsomal epoxide hydrolase (EPHX1) through interaction with the E1b far upstream promoter. Gene 2014, 536:135-144.
109. Su S., Yang X., Omiecinski C.J. Intronic DNA elements regulate Nrf2 chemical responsiveness of the human microsomal epoxide hydrolase gene (EPHX1) through a far upstream alternative promoter. Biochim. Biophys. Acta. 2014, 1839:493-505.
110. Tacconelli S., Patrignani P. Inside epoxyeicosatrienoic acids and cardiovascular disease. Front. Pharmacol. 2014, 5:239.
111. Tan X., Wang Y.Y., Chen X.Y., Xian L., Guo J.J., Liang G.B., Chen M.W. Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer. Genet. Mol. Res. 2014, 13:7437-7446.
112. Tumer T.B., Sahin G., Arinç E. Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia. Arch. Toxicol. 2012, 86:431-439.
113. van der Logt E.M., Bergevoet S.M., Roelofs H.M., Te Morsche R.H., Yv Dijk, Wobbes T., Nagengast F.M., Peters W.H. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat. Res. 2006, 593:39-49.
114. van Loo B., Kingma J., Arand M., Wubbolts M.G., Janssen D.B. Diversity and biocatalytic potential of epoxide hydrolases identified by genome analysis. Appl. Environ. Microbiol. 2006, 72:2905-2917.
115. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., Hemminki K. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat. Res. 2001, 482:89-103.
116. Vodicka P., Kumar R., Stetina R., Musak L., Soucek P., Haufroid V., Sasiadek M., Vodickova L., Naccarati A., Sedikova J., Sanyal S., Kuricova M., Brsiak V., Norppa H., Buchancova J., Hemminki K. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ. Mol. Mutagen. 2004, 44:283-292.
117. Vodicka P., Polivkova Z., Sytarova S., Demova H., Kucerova M., Vodickova L., Polakova V., Naccarati A., Smerhovsky Z., Ambrus M., Cerna M., Hemminki K. Chromosomal damage in peripheral blood lymphocytes of newly diagnosed cancer patients and healthy controls. Carcinogenesis 2010, 31:1238-1241.
118. Vogel-Bindel U., Bentley P., Oesch F. Endogenous role of microsomal epoxide hydrolase. Ontogenesis, induction inhibition, tissue distribution, immunological behaviour and purification of microsomal epoxide hydrolase with 16alpha, 17alpha-epoxyandrostene-3-one as substrate. Eur. J. Biochem. 1982, 126:425-431.
119. Walsh J., Jenkins R.E., Wong M., Olayanju A., Powell H., Copple I., O'Neill P.M., Goldring C.E., Kitteringham N.R., Park B.K. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications. J. Proteomics 2014, 108:171-187.
120. Wang S., Zhu J., Zhang R., Wang S., Gu Z. Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer. Tumour Biol. 2013, 34:1045-1052.
121. Watabe T., Kanehira S. Solubilization of epoxide hydrolase from liver microsomes. Chem. Pharm. Bull. (Tokyo) 1970, 18:1295-1296.
122. Willey J.C., Coy E., Brolly C., Utell M.J., Frampton M.W., Hammersley J., Thilly W.G., Olson D., Cairns K. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol. 1996, 14:262-271.
123. Wong N.A., Rae F., Bathgate A., Smith C.A., Harrison D.J. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol. Lett. 2000, 115:17-22.
124. Xing C., Chen Q., Li G., Zhang L., Zheng M., Zou Z., Hou L., Wang Q.F., Liu X., Guo X. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers. Environ. Mol. Mutagen. 2013, 54:397-405.
125. Yamada T., Morisseau C., Maxwell J.E., Argiriadi M.A., Christianson D.W., Hammock B.D. Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase. J. Biol. Chem. 2000, 275:23082-23088.
126. Yang X., Liang S.H., Weyant D.M., Lazarus P., Gallagher C.J., Omiecinski C.J. The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. J. Pharmacol. Exp. Ther. 2009, 330:23-30.
127. Zhao Z.Q., Guan Q.K., Yang F.Y., Zhao P., Zhou B., Chen Z.J. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk. Tumour Biol. 2012, 33:523-535.
128. Zhu Q., Xing W., Qian B., von Dippe P., Shneider B.L., Fox V.L., Levy D. Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia. Biochim. Biophys. Acta 2003, 1638:208-216.
129. Zhu Q.S., Qian B., Levy D. CCAAT/enhancer-binding protein alpha (C/EBPalpha) activates transcription of the human microsomal epoxide hydrolase gene (EPHX1) through the interaction with DNA-bound NF-Y. J. Biol. Chem. 2004, 279:29902-29910.
130. Zou J., Hallberg B.M., Bergfors T., Oesch F., Arand M., Mowbray S.L., Jones T.A. Structure of Agergillus niger epoxide hydrolase at 1.8Å resolution: implications for the structure and function of the mammalian microsomal class of epoxide hydrolases. Struct. Fold. Des. 2000, 8:111-122.
131. Zusterzeel P.L.M., Peters W.H.M., Visser W., Hermsen K.J.M., Roelofs H.M.J., Steegers E.A.P. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J. Med. Genet. 2001, 38:234-237.